Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis Read more about Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure Read more about Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Dose Escalation and Proof-of-Concept Studies of Vactosertib (TEW-7197) Monotherapy in Patients With MDS Read more about Dose Escalation and Proof-of-Concept Studies of Vactosertib (TEW-7197) Monotherapy in Patients With MDS
An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children Read more about An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children
CBT for Adherence and Depression in Diabetes Read more about CBT for Adherence and Depression in Diabetes
A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness Read more about A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness
Observational Study of Obstructive Lung Disease (NOVELTY) Read more about Observational Study of Obstructive Lung Disease (NOVELTY)
A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis Read more about A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis
Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1 Read more about Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1
FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer Read more about FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer